DK0450021T3 - Anti-cancerforbindelser - Google Patents

Anti-cancerforbindelser

Info

Publication number
DK0450021T3
DK0450021T3 DK90915322.3T DK90915322T DK0450021T3 DK 0450021 T3 DK0450021 T3 DK 0450021T3 DK 90915322 T DK90915322 T DK 90915322T DK 0450021 T3 DK0450021 T3 DK 0450021T3
Authority
DK
Denmark
Prior art keywords
group
pct
hydroxy
nhr
sec
Prior art date
Application number
DK90915322.3T
Other languages
English (en)
Inventor
Laurence Hylton Patterson
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of DK0450021T3 publication Critical patent/DK0450021T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/50—Amino-hydroxy-anthraquinones; Ethers and esters thereof
    • C09B1/51—N-substituted amino-hydroxy anthraquinone
    • C09B1/515—N-alkyl, N-aralkyl or N-cycloalkyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90915322.3T 1989-10-13 1990-10-12 Anti-cancerforbindelser DK0450021T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898923075A GB8923075D0 (en) 1989-10-13 1989-10-13 Anti-cancer compounds

Publications (1)

Publication Number Publication Date
DK0450021T3 true DK0450021T3 (da) 1994-03-07

Family

ID=10664506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90915322.3T DK0450021T3 (da) 1989-10-13 1990-10-12 Anti-cancerforbindelser

Country Status (14)

Country Link
US (1) US5132327A (da)
EP (1) EP0450021B1 (da)
JP (1) JP2854971B2 (da)
AT (1) ATE101181T1 (da)
AU (1) AU634125B2 (da)
CA (1) CA2038934C (da)
DE (1) DE69006482T2 (da)
DK (1) DK0450021T3 (da)
ES (1) ES2062558T3 (da)
GB (2) GB8923075D0 (da)
NZ (1) NZ235658A (da)
PT (1) PT95584B (da)
WO (1) WO1991005824A1 (da)
ZA (1) ZA908178B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141957A (en) * 1990-11-02 1992-08-25 Sphinx Pharmaceuticals Corporation 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
GB9107852D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
GB9107843D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
GB9813062D0 (en) * 1998-06-18 1998-08-19 Univ Wales Medicine An anthraquinone and its derivatives
GB9815910D0 (en) 1998-07-21 1998-09-23 Btg Int Ltd Synthetic method
FR2786484B1 (fr) * 1998-11-30 2001-01-05 Oreal Aminoanthraquinones cationiques, leur utilisation pour la teinture des fibres keratiniques, compositions tinctoriales les renfermant et procedes de teinture
GB9828670D0 (en) * 1998-12-24 1999-02-17 Univ Montfort Anthraquinone anticancer drugs
GB0112868D0 (en) * 2001-05-25 2001-07-18 Secr Defence Detection system
JP2006501140A (ja) 2002-03-15 2006-01-12 ビーティージー・インターナショナル・リミテッド アントラキノン誘導体の調製
GB0223563D0 (en) * 2002-10-10 2002-11-20 Secr Defence Detection system
US6949557B2 (en) * 2003-04-29 2005-09-27 Dabur Research Foundation Hydroanthracene based compounds as anticancer agents
US20050009924A1 (en) * 2003-07-08 2005-01-13 Hsu-Shan Huang Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives
EP1663147A1 (en) * 2003-09-17 2006-06-07 Btg International Limited Formulations of anthraquinone derivatives
JP2007516270A (ja) * 2003-12-23 2007-06-21 ソマンタ リミテッド 抗ガン性化合物としてのアントラキノン化合物
JP2007522194A (ja) * 2004-02-13 2007-08-09 クドス ファーマシューティカルズ リミテッド Ａｑ４ｎの製造方法
WO2005097128A1 (en) * 2004-03-30 2005-10-20 Novacea, Inc. 1,4-bis-n-oxide azaanthracenediones and the use thereof
CN101193644A (zh) * 2005-03-04 2008-06-04 诺瓦西股份有限公司 使用蒽醌类治疗过度增殖性疾病
US20070117784A1 (en) * 2005-03-04 2007-05-24 Novacea, Inc. Treatment of hyperproliferative diseases with anthraquinones
WO2008103320A1 (en) * 2007-02-16 2008-08-28 Novacea, Inc. Methods of treating ophthalmic disorders with anthraquinones
US8999965B2 (en) 2008-10-27 2015-04-07 Life Technologies Corporation Anthraquinone based near IR emitting compounds and uses thereof
GB201005939D0 (en) 2010-04-09 2010-05-26 Biostatus Ltd Method of analysing a cell or other biological material containing nucleic acid
GB201214169D0 (en) * 2012-08-08 2012-09-19 Biostatus Ltd New compounds and uses thereof
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
US9272981B1 (en) * 2015-06-23 2016-03-01 Amazon Technologies, Inc. Method of preparing a compound
US11292803B2 (en) 2018-08-21 2022-04-05 The Board Of Trustees Of The University Of Illinois Bioreducible N-oxide-based probes for imaging of hypoxia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE194218C (da) *
US3174994A (en) * 1962-01-30 1965-03-23 Smith Kline French Lab Hypocholesterolemic n-oxide compositions
ZA774443B (en) * 1977-07-22 1978-06-28 Allied Chem Anthrquinone compounds as anti-cancer agents
US4820738A (en) * 1977-08-15 1989-04-11 American Cyanamid Company 1,4-bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4430501A (en) * 1979-08-02 1984-02-07 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4278689A (en) * 1978-07-11 1981-07-14 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4540519A (en) * 1977-08-15 1985-09-10 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4138415A (en) * 1978-05-05 1979-02-06 American Cyanamid Company 1,4-Bis(aminoalkylamino)-anthraquinones and leuco derivatives thereof
US4197249A (en) * 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4526989A (en) * 1978-07-11 1985-07-02 American Cyanamid Company 1,4-Bis (substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
US4614618A (en) * 1979-08-02 1986-09-30 American Cyanamid Company 1,4-bis(substituted-amino)-5,8-dihydroxy anthraquinones and leuco bases thereof
US4275010A (en) * 1979-10-24 1981-06-23 American Cyanamid Company 5,8-Dihydroxy-1,4-bis(guanidinylamino)anthraquinones
US4278605A (en) * 1980-06-30 1981-07-14 American Cyanamid Company Heteroalkylenebisanthraquinones
US4555572A (en) * 1983-07-19 1985-11-26 Warner-Lambert Company Pyrazolo[3,4,5-kl]acridine compositions and methods for their production and use
US4626540A (en) * 1983-11-08 1986-12-02 Warner-Lambert Company Substituted 1-amino-4-nitro-acridinones and methods of treating bacterial infections and leukemia with them
US4686218A (en) * 1985-01-30 1987-08-11 Smithkline Beckman Corporation Use of 6-chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine-n-oxide, as a prodrug
US4963554A (en) * 1990-02-14 1990-10-16 Ortho Pharmaceutical Corporation 6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides

Also Published As

Publication number Publication date
GB8923075D0 (en) 1989-11-29
US5132327A (en) 1992-07-21
AU634125B2 (en) 1993-02-11
EP0450021B1 (en) 1994-02-02
JP2854971B2 (ja) 1999-02-10
GB2237283B (en) 1993-01-27
DE69006482D1 (de) 1994-03-17
ES2062558T3 (es) 1994-12-16
CA2038934A1 (en) 1991-04-14
PT95584A (pt) 1991-09-13
EP0450021A1 (en) 1991-10-09
GB2237283A (en) 1991-05-01
GB9022217D0 (en) 1990-11-28
DE69006482T2 (de) 1994-05-11
WO1991005824A1 (en) 1991-05-02
NZ235658A (en) 1992-12-23
ATE101181T1 (de) 1994-02-15
AU6539590A (en) 1991-05-16
ZA908178B (en) 1992-06-24
JPH04502166A (ja) 1992-04-16
CA2038934C (en) 2002-11-19
PT95584B (pt) 1997-08-29

Similar Documents

Publication Publication Date Title
DK0450021T3 (da) Anti-cancerforbindelser
LU90988I2 (fr) Ebixa-mémantine e ses dérivés pharmaceutiquement acceptables
PT1140851E (pt) 4-oxo-1,4-di-hidro-3-quinolinacarboxamidas como agentes antivirais
PT87147A (pt) Procede de preparation des nouveaux derives de l:amino tetrahydro-5,6,7,8 naphto ]2,3b" furanne
ES2098023T3 (es) Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen.
YU48136B (sh) Morfolinil derivati doksorubicina i postupak za njihovo dobijanje
ES2072536T3 (es) Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica.
GB2254613B (en) Anti-cancer anthracene compounds
ES2075429T3 (es) Derivados de 4,5-cicloalcano-3-benzazepin-7-ol y sus usos.
DK0456133T3 (da) Hydrazoner
DE69118064D1 (de) Diamino-s-Triazinonderivate und diese enthaltende selbstlöschende polymere Zusammensetzungen
DK540684A (da) Benzoquinoliziner
FI941958A (fi) 2-heterosyklinenetyyliamiinijohdannaiset ja niiden käyttö lääkkeinä
ATE83776T1 (de) 1,2-benzisoxazole und 1,2-benzisothiazole.
SE8304545L (sv) Bensamidderivat
IT1272881B (it) Composti arilalchilenici